Trent M Woodruff Selected Research

WL 19

10/2013

A small molecule angiotensin II type 2 receptor (AT₂R) antagonist produces analgesia in a rat model of neuropathic pain by inhibition of p38 mitogen-activated protein kinase (MAPK) and p44/p42 MAPK activation in the dorsal root ganglia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Trent M Woodruff Research Topics

Disease

31	Inflammation (Inflammations) 01/2022 - 01/2006
15	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021 - 12/2008
11	Neuroinflammatory Diseases 01/2021 - 07/2009
11	Reperfusion Injury 01/2020 - 04/2002
10	Infections 01/2020 - 06/2010
9	Disease Progression 11/2020 - 05/2015
8	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 04/2010
7	Ischemia 01/2020 - 04/2002
7	Wounds and Injuries (Trauma) 01/2019 - 04/2002
6	Edema (Dropsy) 01/2015 - 04/2002
6	Stroke (Strokes) 06/2012 - 01/2008
5	Neoplasms (Cancer) 01/2022 - 10/2019
5	Body Weight (Weight, Body) 10/2020 - 05/2005
5	Spinal Cord Injuries (Spinal Cord Injury) 01/2019 - 06/2012
5	Neuralgia (Stump Neuralgia) 01/2018 - 10/2013
4	Ischemic Stroke 01/2020 - 01/2008
4	Sepsis (Septicemia) 12/2019 - 08/2006
4	Alzheimer Disease (Alzheimer's Disease) 10/2019 - 04/2010
4	Necrosis 02/2019 - 05/2005
3	Atherosclerosis 12/2021 - 07/2011
3	Pain (Aches) 01/2021 - 01/2016
3	Fibrosis (Cirrhosis) 01/2020 - 11/2011
3	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2018 - 06/2012
3	Neural Tube Defects (Exencephaly) 03/2016 - 04/2013
3	Pre-Eclampsia (Preeclampsia) 09/2015 - 01/2013
3	Rheumatoid Arthritis 05/2012 - 03/2011
3	Neutropenia 08/2006 - 04/2002
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2005 - 11/2003
3	Colitis 08/2005 - 11/2003
2	Cancer Pain 10/2022 - 05/2020
2	Epilepsy (Aura) 01/2022 - 04/2015
2	Chronic Disease (Chronic Diseases) 01/2022 - 10/2019
2	Schizophrenia (Dementia Praecox) 01/2022 - 10/2019
2	Thromboinflammation 12/2021 - 01/2019
2	Bites and Stings (Sting) 01/2021 - 01/2020
2	Acute Lung Injury 01/2021 - 11/2012
2	COVID-19 11/2020 - 01/2020
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020 - 08/2006
2	Hypertension (High Blood Pressure) 01/2020 - 11/2011
2	Meningococcal Infections 12/2019 - 01/2018
2	Melanoma (Melanoma, Malignant) 10/2019 - 01/2016
2	Carcinogenesis 10/2019 - 01/2016
2	Brain Injuries (Brain Injury) 10/2019 - 01/2008
2	Parkinson Disease (Parkinson's Disease) 10/2018 - 01/2016
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2018 - 06/2015
2	Burns 01/2018 - 08/2006
2	Huntington Disease (Huntington's Disease) 01/2016 - 07/2006
2	Hyperalgesia 01/2016 - 06/2015
2	Premature Birth (Birth, Premature) 08/2015 - 01/2013
2	Arthritis (Polyarthritis) 03/2011 - 09/2002

Drug/Important Bio-Agent (IBA)

52	Complement System Proteins (Complement)IBA 01/2022 - 04/2002
15	Anaphylatoxin C5a ReceptorIBA 10/2019 - 04/2002
11	Complement C5a (Complement 5a)IBA 01/2022 - 07/2011
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2004
7	Peptides (Polypeptides)IBA 01/2022 - 05/2012
5	Analgesics (Analgesic Drugs)IBA 10/2022 - 10/2013
5	Peroxidase (Myeloperoxidase)IBA 01/2022 - 11/2003
5	CytokinesIBA 01/2022 - 01/2015
5	Complement Receptors (Complement Receptor)IBA 01/2021 - 04/2015
5	Pharmaceutical PreparationsIBA 01/2020 - 11/2003
5	LigandsIBA 10/2019 - 01/2015
5	hydrocinnamate- cyclo(ornithyl- prolyl- cyclohexylalanyl- tryptophyl- arginyl)IBA 01/2017 - 08/2005
5	AcPhe(ornithine- Pro- cyclohexylamine- Trp- Arg)IBA 01/2006 - 04/2002
4	HMGB1 Protein (HMG1)IBA 01/2022 - 03/2013
4	InflammasomesIBA 01/2020 - 10/2017
4	AnaphylatoxinsIBA 12/2019 - 01/2016
4	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2019 - 08/2011
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2006 - 04/2002
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2020
3	Messenger RNA (mRNA)IBA 01/2021 - 10/2017
3	ChemokinesIBA 01/2021 - 10/2017
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 09/2012
3	Protein AggregatesIBA 01/2020 - 12/2017
3	Folic Acid (Vitamin M)FDA LinkGeneric 03/2016 - 04/2013
3	Factor VaIBA 08/2015 - 04/2002
3	Cyclic PeptidesIBA 01/2006 - 04/2002
3	Sulfonic AcidsIBA 08/2005 - 11/2003
2	Ketamine FDA LinkGeneric 10/2022 - 05/2020
2	lepirudin (Refludan)FDA Link 01/2022 - 12/2021
2	Biological ProductsIBA 12/2021 - 01/2018
2	CholesterolIBA 12/2021 - 01/2019
2	Receptor for Advanced Glycation End ProductsIBA 10/2020 - 01/2015
2	Complement Inactivating AgentsIBA 01/2020 - 01/2008
2	Interleukin-6 (Interleukin 6)IBA 10/2017 - 04/2015
2	EphrinsIBA 02/2016 - 11/2012
2	CollagenIBA 01/2016 - 11/2011
2	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2015 - 07/2009
2	Complement C3a (Complement 3a)IBA 12/2014 - 05/2012
2	Infliximab (Remicade)FDA Link 03/2011 - 11/2003
2	AntigensIBA 03/2011 - 09/2002
2	Prednisolone (Predate)FDA LinkGeneric 03/2011 - 11/2003
2	EnzymesIBA 03/2011 - 05/2005
2	Secretory Phospholipases A2IBA 03/2011 - 05/2005
2	Group II Phospholipases A2IBA 03/2011 - 05/2005
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Snake Venoms (Snake Venom)IBA 01/2022
1	FibrinIBA 01/2022
1	AnticoagulantsIBA 01/2022

Therapy/Procedure

12	Therapeutics 01/2022 - 07/2009
3	Drug Therapy (Chemotherapy) 01/2011 - 05/2004